Latest hair loss research brings new hope in the treatment of male pattern baldness.
A triple blind hair loss research involved two FDA-approved hair growth medications: Minoxidil and Finesteride.
Three groups of people were used in the study: Group I was the placebo group, Group II applied 5% Minoxidil lotion, Group III applied 5% Minoxidil lotion, 0.025% tretinoin (Retin A) and 0.1% Finesteride.
The subjects were evaluated every six months with the help of a subjective questionnaire, objective examination and close-up photographs.
In the Placebo Group, there was neither any improvement nor deterioration. In the Minoxidil Group 25% of the subjects showed hair growth.
In the Combination Group as much as 75% of the subjects showed improvement. The quality of the newly grown hair was also better in the combination group.
This study served as the basis for the development of ProMox – new and promising hair loss product for men created by Dr. Oscar Klein.
Visit: www.HairGrowthMD.com for more details.
Read related articles:
- Latest in Hair Loss News -Stanford University scientists have made an important discovery that can help in dealing with hair loss....
- New Hair Loss Treatment for Women -The shame of hair loss in women is still huge. The estimated number of 30 million...
- Natural Cures for Hair Loss -Both men and women suffer from hair loss problem. Most of them choose expensive solutions to...
- Most Americans Don’t Know Causes of Hair Loss -Most Americans are unclear on the true causes of hair loss. According to a new national...
- Hair Loss Gene Discovered! -A hair loss gene has been identified by scientists who now hope to find a cure....
